爱得科技过会：今年IPO过关第79家 德邦证券过2单

Core Viewpoint - Suzhou Aide Technology Development Co., Ltd. has been approved for its initial public offering (IPO) on the Beijing Stock Exchange, marking it as the 79th company to pass the review this year [1]. Company Overview - Aide Technology specializes in the research, production, and sales of orthopedic medical devices, focusing on products such as spinal, trauma, and sports medicine consumables, as well as wound healing products [1]. - The company is primarily controlled by Lu Qiang and Huang Meiyu, who together hold 79.07% of the shares, with Lu holding 34.99% and Huang holding 38.78% directly, along with additional control through a management company [1]. IPO Details - Aide Technology plans to publicly issue between 1 million and 29.53 million shares, with a potential over-allotment option of up to 442,961.4 shares, which is 15% of the total offering [2]. - The company aims to raise approximately 197.0189 million yuan for projects including the expansion of orthopedic consumables production, the establishment of a research and development center, and the development of a marketing network [2]. Review and Inquiry - The review committee raised inquiries regarding the stability of the company's performance, particularly the impact of centralized procurement policies on product pricing, costs, gross margins, and overall business performance [3]. - Questions were also posed about the authenticity of the company's distribution revenue, including the rationale behind the significant changes in the number of distributors and whether these changes align with sales figures and the number of hospitals in different regions [3].